NEW YORK (GenomeWeb) – Qiagen has received a warning letter from the US Food and Drug Administration regarding its QuantiFeron-TB Gold blood test for tuberculosis diagnosis. The agency said there have been multiple complaints about the test's high rate of false positives and that it has been misbranded, among other violations of federal law.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.